QA: Chinook Therapeutics INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001435049_2019_Chinook_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001435049, Chinook Therapeutics INC

  xvar xval
0 AssetsCurrent 282,976,000
1 IntangibleAssetsNetIncludingGoodwill 33,469,000
2 PropertyPlantAndEquipmentNet 29,157,000
3 remainder_Assets 11,902,000
4 LiabilitiesCurrent 30,517,000
5 LiabilitiesNoncurrent 173,511,000
6 remainder_Liabilities 18,165,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,660,569
9 ResearchAndDevelopmentExpense 66,764,781
10 remainder_Expenses 825,781
11 remainder_Revenues 15,311,779
12 remainder_NetIncome 15,085,494
13 remainder_ComprehensiveNetIncome 3,558,482
  yvar yval
0 Assets 357,504,000
1 Liabilities 222,193,000
2 Expenses 104,251,131
3 Revenues 15,311,779
4 StockholdersEquity 135,311,000
5 NetIncome -73,853,858
6 ComprehensiveNetIncome -72,074,617
7 BaseVar 358,951,943
8 EconomicCapitalRatiobeforeLimitedLiability 0.769
9 EconomicCapitalRatio 2.11

Edgar->Model Mapping

Feature Distribution

Change over Time